- Home
- CMBM vs ALLR Comparison
CMBM vs ALLR Comparison
Compare CMBM & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMBM
- ALLR
- Stock Information
- Founded
- CMBM 2011
- ALLR 2004
- Country
- CMBM United States
- ALLR United States
- Employees
- CMBM N/A
- ALLR N/A
- Industry
- CMBM Radio And Television Broadcasting And Communications Equipment
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- CMBM Technology
- ALLR Health Care
- Exchange
- CMBM Nasdaq
- ALLR Nasdaq
- Market Cap
- CMBM 25.0M
- ALLR 21.8M
- IPO Year
- CMBM 2019
- ALLR N/A
- Fundamental
- Price
- CMBM $0.64
- ALLR $1.45
- Analyst Decision
- CMBM Buy
- ALLR Strong Buy
- Analyst Count
- CMBM 1
- ALLR 1
- Target Price
- CMBM $3.00
- ALLR $9.25
- AVG Volume (30 Days)
- CMBM 200.8K
- ALLR 336.8K
- Earning Date
- CMBM 11-06-2025
- ALLR 11-13-2025
- Dividend Yield
- CMBM N/A
- ALLR N/A
- EPS Growth
- CMBM N/A
- ALLR N/A
- EPS
- CMBM N/A
- ALLR N/A
- Revenue
- CMBM $172,215,000.00
- ALLR N/A
- Revenue This Year
- CMBM N/A
- ALLR N/A
- Revenue Next Year
- CMBM $17.73
- ALLR N/A
- P/E Ratio
- CMBM N/A
- ALLR N/A
- Revenue Growth
- CMBM N/A
- ALLR N/A
- 52 Week Low
- CMBM $0.23
- ALLR $0.61
- 52 Week High
- CMBM $1.69
- ALLR $2.35
- Technical
- Relative Strength Index (RSI)
- CMBM 39.09
- ALLR 43.95
- Support Level
- CMBM $0.75
- ALLR $1.40
- Resistance Level
- CMBM $0.87
- ALLR $1.53
- Average True Range (ATR)
- CMBM 0.09
- ALLR 0.12
- MACD
- CMBM -0.03
- ALLR -0.03
- Stochastic Oscillator
- CMBM 11.67
- ALLR 17.65
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.